{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:20:35Z","timestamp":1792844435006,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["APQ-02064-15"],"award-info":[{"award-number":["APQ-02064-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jpsychires.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T18:31:55Z","timestamp":1523039515000},"page":"142-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-751X","authenticated-orcid":false,"given":"Juliana R.","family":"Bastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherinne M.","family":"Perico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rica L.","family":"Marciano Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline S.","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcio A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.04.004_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejphar.2015.08.053","article-title":"The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice","volume":"765","author":"Almeida-Santos","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/mp.2010.101","article-title":"Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys","volume":"16","author":"Alonso","year":"2011","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.euroneuro.2007.03.002","article-title":"Chronic amphetamine treatment reduces NGF and BDNF in the rat brain","volume":"17","author":"Angelucci","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00406-003-0437-2","article-title":"Recurrence of bipolar disorders and major depression. A life-long perspective","volume":"253","author":"Angst","year":"2003","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib5","doi-asserted-by":"crossref","first-page":"360481","DOI":"10.1155\/2014\/360481","article-title":"Cytokines in bipolar disorder: paving the way for neuroprogression","volume":"2014","author":"Barbosa","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000356539","article-title":"The immunology of bipolar disorder","volume":"21","author":"Barbosa","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.rbp.2012.05.011","article-title":"Increased BDNF levels in long-term bipolar disorder patients","volume":"35","author":"Barbosa","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2014.00254","article-title":"BDNF signaling and survival of striatal neurons","volume":"8","author":"Baydyuk","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib9","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jpsychires.2016.10.003","article-title":"Epidemiology of DSM-5 bipolar I disorder: results from the national epidemiologic survey on alcohol and related conditions - III","volume":"84","author":"Blanco","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","article-title":"The role of dopamine in bipolar disorder","volume":"11","author":"Cousins","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","article-title":"Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes","volume":"398","author":"Cunha","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainresbull.2016.10.008","article-title":"Preventive effects of blueberry extract on behavioral and biochemical dysfunctions in rats submitted to a model of manic behavior induced by ketamine","volume":"127","author":"Debom","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/HRP.0000000000000059","article-title":"New ways of modeling bipolar disorder","volume":"22","author":"Einat","year":"2014","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainres.2014.07.001","article-title":"Up-regulation of brain cytokines and chemokines mediates neurotoxicity in early acute liver failure by a mechanism independent of microglial activation","volume":"1578","author":"Faleiros","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2006.01.002","article-title":"Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania","volume":"79","author":"Frey","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neubiorev.2007.05.007","article-title":"Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement","volume":"31","author":"Gould","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","article-title":"Role of P2X7 receptor in an animal model of mania induced by d-amphetamine","volume":"53","author":"Gubert","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbi.2014.03.016","article-title":"Neuroinflammation in bipolar disorder - a [(11)C]-(R)-PK11195 positron emission tomography study","volume":"40","author":"Haarman","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib23","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.metabol.2014.10.026","article-title":"Biomarkers of psychiatric diseases: current status and future prospects","volume":"64","author":"Kalia","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","article-title":"Bipolar disorder: role of inflammation and the development of disease biomarkers","volume":"13","author":"Muneer","year":"2016","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib26","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","article-title":"A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men","volume":"66","author":"Perry","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib27","first-page":"645","article-title":"Reliable biomarkers and predictors of schizophrenia and its treatment","volume":"35","author":"Pillai","year":"2012","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s11011-015-9697-6","article-title":"GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs","volume":"30","author":"Queiroz","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2015.05.018","article-title":"The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders","volume":"300","author":"Reus","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib31","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/acps.12414","article-title":"Are medical comorbid conditions of bipolar disorder due to immune dysfunction?","volume":"132","author":"Rosenblat","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12271","article-title":"International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder","volume":"17","author":"Schaffer","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pnpbp.2014.08.013","article-title":"The role of neurotrophins in bipolar disorder","volume":"56","author":"Scola","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pnpbp.2015.11.001","article-title":"Modeling mania in preclinical settings: a comprehensive review","volume":"66","author":"Sharma","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib37","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/14737159.2016.1248413","article-title":"Update on bipolar disorder biomarker candidates","volume":"16","author":"Teixeira","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Trepanier","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bdi.12299","article-title":"Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine","volume":"17","author":"Valvassori","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib42","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s00213-015-4000-4","article-title":"Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features","volume":"232","author":"van Enkhuizen","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpsychires.2014.11.003","article-title":"Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats","volume":"61","author":"Varela","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bcpt.12036","article-title":"Effects of aripiprazole, an atypical antipsychotic, on the motor alterations induced by acute ethanol administration in mice","volume":"112","author":"Viana","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib45","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.euroneuro.2016.10.012","article-title":"Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: ketamine and lisdexamfetamine-induced hyperlocomotion in rats","volume":"26","author":"Wendler","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2015.03.019","article-title":"Investigating the mechanism(s) underlying switching between states in bipolar disorder","volume":"759","author":"Young","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-009-1744-8","article-title":"GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior","volume":"208","author":"Young","year":"2010","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2018.04.004_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","article-title":"The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration","volume":"96","author":"Young","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib50","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib51","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","article-title":"A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor","volume":"31","author":"Young","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(99)02063-6","article-title":"Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats","volume":"847","author":"Zalcman","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)02090-X","article-title":"Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity","volume":"899","author":"Zalcman","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2018.04.004_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(02)02740-3","article-title":"Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists","volume":"944","author":"Zalcman","year":"2002","journal-title":"Brain Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618300268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618300268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T02:55:55Z","timestamp":1575341755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618300268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":54,"alternative-id":["S0022395618300268"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.04.004","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}